
### [NCIT:C3608](http://purl.obolibrary.org/obo/NCIT_C3608)
**Label:** Benign Uterine Corpus Neoplasm

**Subclasses:** [NCIT:C3434](http://purl.obolibrary.org/obo/NCIT_C3434) (Uterine Corpus Leiomyoma), [NCIT:C3511](http://purl.obolibrary.org/obo/NCIT_C3511) (Uterine Corpus Degenerated Leiomyoma), [NCIT:C5356](http://purl.obolibrary.org/obo/NCIT_C5356) (Uterine Corpus Intravenous Leiomyomatosis), [NCIT:C4894](http://purl.obolibrary.org/obo/NCIT_C4894) (Benign Endometrial Neoplasm), [NCIT:C6335](http://purl.obolibrary.org/obo/NCIT_C6335) (Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C6338](http://purl.obolibrary.org/obo/NCIT_C6338) (Uterine Corpus Adenomyoma), [NCIT:C6337](http://purl.obolibrary.org/obo/NCIT_C6337) (Uterine Corpus Adenofibroma), [NCIT:C6433](http://purl.obolibrary.org/obo/NCIT_C6433) (Endometrial Polyp), [NCIT:C4262](http://purl.obolibrary.org/obo/NCIT_C4262) (Endometrial Stromal Nodule), [NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma), [NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma), [NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma), [NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma), [NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma), [NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant), [NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma), [NCIT:C27250](http://purl.obolibrary.org/obo/NCIT_C27250) (Uterine Corpus Adenomatoid Tumor), [NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis), 

**Class expressions from DL-Learner:**

- Thing 54.15%
- [NCIT:C53993](http://purl.obolibrary.org/obo/NCIT_C53993) (Plexiform Vasculature Present) 51.92%
- [NCIT:C53992](http://purl.obolibrary.org/obo/NCIT_C53992) (Infiltrating Tumor Margins Present) 51.92%
- [NCIT:C53991](http://purl.obolibrary.org/obo/NCIT_C53991) (Pushing Tumor Margin) 51.92%
- [NCIT:C49120](http://purl.obolibrary.org/obo/NCIT_C49120) (Lipomatous Metaplasia) 51.92%
- [NCIT:C41428](http://purl.obolibrary.org/obo/NCIT_C41428) (Increased Cellularity Present) 51.92%
- [NCIT:C35380](http://purl.obolibrary.org/obo/NCIT_C35380) (Hemorrhagic Change) 51.92%
- [NCIT:C137709](http://purl.obolibrary.org/obo/NCIT_C137709) (Tumor Margin Configuration) 51.92%
- [NCIT:C53682](http://purl.obolibrary.org/obo/NCIT_C53682) (Thick-Walled Vessels Present) 37.28%
- [NCIT:C53682](http://purl.obolibrary.org/obo/NCIT_C53682) (Thick-Walled Vessels Present) and (not ([NCIT:C40041](http://purl.obolibrary.org/obo/NCIT_C40041) (Ovarian Mucinous Cystadenofibroma))) 37.28%
- [NCIT:C53682](http://purl.obolibrary.org/obo/NCIT_C53682) (Thick-Walled Vessels Present) and (not ([NCIT:C40034](http://purl.obolibrary.org/obo/NCIT_C40034) (Ovarian Mucinous Adenocarcinofibroma))) 37.28%
- [NCIT:C53682](http://purl.obolibrary.org/obo/NCIT_C53682) (Thick-Walled Vessels Present) and (not ([NCIT:C40032](http://purl.obolibrary.org/obo/NCIT_C40032) (Ovarian Serous Cystadenofibroma))) 37.28%
- [NCIT:C53682](http://purl.obolibrary.org/obo/NCIT_C53682) (Thick-Walled Vessels Present) and (not ([NCIT:C40029](http://purl.obolibrary.org/obo/NCIT_C40029) (Borderline Ovarian Serous Cystadenofibroma))) 37.28%
- [NCIT:C53682](http://purl.obolibrary.org/obo/NCIT_C53682) (Thick-Walled Vessels Present) and (not ([NCIT:C40021](http://purl.obolibrary.org/obo/NCIT_C40021) (Ovarian Lymphoma))) 37.28%
- [NCIT:C53682](http://purl.obolibrary.org/obo/NCIT_C53682) (Thick-Walled Vessels Present) and (not ([NCIT:C4002](http://purl.obolibrary.org/obo/NCIT_C4002) (Extraosseous Plasmacytoma))) 37.28%


